Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach
<p>Abstract</p> <p>Background</p> <p>Anti-malarial drugs are constantly exposed to the threat of evolving drug resistance so good stewardship of existing therapy is an essential component of public health policy. However, the widespread availability of numerous differen...
Main Authors: | Antao Tiago, Hastings Ian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://www.malariajournal.com/content/11/1/422 |
Similar Items
-
Elemental composition in monocytes in response to anti-malarial drugs and hemozoin.
by: Hiltunen, Tamara Ann.
Published: (2013) -
ANTI-MALARIAL DRUG RESISTANCE
by: Yenni Yusuf
Published: (2014-05-01) -
Progress and challenges in the use of fluorescence‐based flow cytometric assays for anti‐malarial drug susceptibility tests
by: Kasem Kulkeaw
Published: (2021-01-01) -
Malária falciparum resistente à cloroquina e ao Fansidar R tratada com minociclina Minocycline treatment of chloroquine-and Fansidar R-resistant falciparum malarial
by: José J. Ferraroni
Published: (1983-08-01) -
Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali
by: Moussa Djimde, et al.
Published: (2019-02-01)